Operating Lease, Right-of-Use Asset of TFF Pharmaceuticals, Inc. from 30 Jun 2022 to 30 Sep 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
TFF Pharmaceuticals, Inc. quarterly Operating Lease, Right-of-Use Asset in USD history and change rate from 30 Jun 2022 to 30 Sep 2024.
  • TFF Pharmaceuticals, Inc. Operating Lease, Right-of-Use Asset for the quarter ending 30 Sep 2024 was $57,990, a 58% decline year-over-year.
Source SEC data
View on sec.gov
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Change (%)

TFF Pharmaceuticals, Inc. Quarterly Operating Lease, Right-of-Use Asset (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q3 2024 $57,990 -$81,240 -58% 30 Sep 2024 10-Q 20 Nov 2024 2024 Q3
Q2 2024 $78,924 -$79,617 -50% 30 Jun 2024 10-Q 14 Aug 2024 2024 Q2
Q1 2024 $99,431 -$78,042 -44% 31 Mar 2024 10-Q 14 May 2024 2024 Q1
Q4 2023 $119,529 -$76,515 -39% 31 Dec 2023 10-Q 20 Nov 2024 2024 Q3
Q3 2023 $139,230 -$75,034 -35% 30 Sep 2023 10-Q 14 Nov 2023 2023 Q3
Q2 2023 $158,541 -$73,597 -32% 30 Jun 2023 10-Q 14 Aug 2023 2023 Q2
Q1 2023 $177,473 31 Mar 2023 10-Q 11 May 2023 2023 Q1
Q4 2022 $196,044 31 Dec 2022 10-K 28 Mar 2024 2023 FY
Q3 2022 $214,264 30 Sep 2022 10-Q 14 Nov 2022 2022 Q3
Q2 2022 $232,138 30 Jun 2022 10-Q 11 Aug 2022 2022 Q2
* An asterisk sign (*) next to the value indicates that the value is likely invalid.